BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18246201)

  • 1. Constitutive activation of SHP2 in mice cooperates with ICSBP deficiency to accelerate progression to acute myeloid leukemia.
    Konieczna I; Horvath E; Wang H; Lindsey S; Saberwal G; Bei L; Huang W; Platanias L; Eklund EA
    J Clin Invest; 2008 Mar; 118(3):853-67. PubMed ID: 18246201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia-associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF1 transcriptional activation by the interferon consensus sequence binding protein.
    Huang W; Saberwal G; Horvath E; Zhu C; Lindsey S; Eklund EA
    Mol Cell Biol; 2006 Sep; 26(17):6311-32. PubMed ID: 16914719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activation of SHP2 protein tyrosine phosphatase inhibits ICSBP-induced transcription of the gene encoding gp91PHOX during myeloid differentiation.
    Zhu C; Lindsey S; Konieczna I; Eklund EA
    J Leukoc Biol; 2008 Mar; 83(3):680-91. PubMed ID: 18089853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interferon consensus sequence binding protein (ICSBP/IRF8) activates transcription of the FANCF gene during myeloid differentiation.
    Saberwal G; Horvath E; Hu L; Zhu C; Hjort E; Eklund EA
    J Biol Chem; 2009 Nov; 284(48):33242-54. PubMed ID: 19801548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia.
    Wang H; Lindsey S; Konieczna I; Bei L; Horvath E; Huang W; Saberwal G; Eklund EA
    J Biol Chem; 2009 Jan; 284(4):2549-67. PubMed ID: 19022774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interferon consensus sequence-binding protein (ICSBP/IRF8) represses PTPN13 gene transcription in differentiating myeloid cells.
    Huang W; Zhu C; Wang H; Horvath E; Eklund EA
    J Biol Chem; 2008 Mar; 283(12):7921-35. PubMed ID: 18195016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcr-abl regulates Stat5 through Shp2, the interferon consensus sequence binding protein (Icsbp/Irf8), growth arrest specific 2 (Gas2) and calpain.
    Hjort EE; Huang W; Hu L; Eklund EA
    Oncotarget; 2016 Nov; 7(47):77635-77650. PubMed ID: 27769062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nf1 haploinsufficiency and Icsbp deficiency synergize in the development of leukemias.
    Koenigsmann J; Rudolph C; Sander S; Kershaw O; Gruber AD; Bullinger L; Schlegelberger B; Carstanjen D
    Blood; 2009 May; 113(19):4690-701. PubMed ID: 19228926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interferon consensus sequence-binding protein activates transcription of the gene encoding neurofibromin 1.
    Zhu C; Saberwal G; Lu Y; Platanias LC; Eklund EA
    J Biol Chem; 2004 Dec; 279(49):50874-85. PubMed ID: 15371411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PU.1, interferon regulatory factor (IRF) 2, and the interferon consensus sequence-binding protein (ICSBP/IRF8) cooperate to activate NF1 transcription in differentiating myeloid cells.
    Huang W; Horvath E; Eklund EA
    J Biol Chem; 2007 Mar; 282(9):6629-43. PubMed ID: 17200120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration of chronic myeloproliferation by enforced expression of Meis1 or Meis3 in Icsbp-deficient bone marrow cells.
    Hara T; Schwieger M; Kazama R; Okamoto S; Minehata K; Ziegler M; Löhler J; Stocking C
    Oncogene; 2008 Jun; 27(27):3865-9. PubMed ID: 18223676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN consensus sequence binding protein/IFN regulatory factor-8 guides bone marrow progenitor cells toward the macrophage lineage.
    Tsujimura H; Nagamura-Inoue T; Tamura T; Ozato K
    J Immunol; 2002 Aug; 169(3):1261-9. PubMed ID: 12133947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interferon Consensus Sequence Binding Protein (Icsbp/Irf8) Is Required for Termination of Emergency Granulopoiesis.
    Hu L; Huang W; Hjort EE; Bei L; Platanias LC; Eklund EA
    J Biol Chem; 2016 Feb; 291(8):4107-20. PubMed ID: 26683374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein.
    Scheller M; Foerster J; Heyworth CM; Waring JF; Löhler J; Gilmore GL; Shadduck RK; Dexter TM; Horak I
    Blood; 1999 Dec; 94(11):3764-71. PubMed ID: 10572090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interferon regulatory factor ICSBP/IRF-8 in combination with PU.1 up-regulates expression of tumor suppressor p15(Ink4b) in murine myeloid cells.
    Schmidt M; Bies J; Tamura T; Ozato K; Wolff L
    Blood; 2004 Jun; 103(11):4142-9. PubMed ID: 14976051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder.
    Hao SX; Ren R
    Mol Cell Biol; 2000 Feb; 20(4):1149-61. PubMed ID: 10648600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis.
    Chan G; Kalaitzidis D; Usenko T; Kutok JL; Yang W; Mohi MG; Neel BG
    Blood; 2009 Apr; 113(18):4414-24. PubMed ID: 19179468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon consensus sequence binding protein (ICSBP) decreases beta-catenin activity in myeloid cells by repressing GAS2 transcription.
    Huang W; Zhou W; Saberwal G; Konieczna I; Horvath E; Katsoulidis E; Platanias LC; Eklund EA
    Mol Cell Biol; 2010 Oct; 30(19):4575-94. PubMed ID: 20679491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells.
    Tamura T; Ozato K
    J Interferon Cytokine Res; 2002 Jan; 22(1):145-52. PubMed ID: 11846985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of SHP2 phosphatase in KIT-induced transformation: identification of SHP2 as a druggable target in diseases involving oncogenic KIT.
    Mali RS; Ma P; Zeng LF; Martin H; Ramdas B; He Y; Sims E; Nabinger S; Ghosh J; Sharma N; Munugalavadla V; Chatterjee A; Li S; Sandusky G; Craig AW; Bunting KD; Feng GS; Chan RJ; Zhang ZY; Kapur R
    Blood; 2012 Sep; 120(13):2669-78. PubMed ID: 22806893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.